The chondrodystrophies (CDX) are a heterogeneous group of disorders of endochondral bone growth that are characterized clinically by shortening and deformities of the limbs and trunk. The delineation of the pathogenetic mechanisms responsible for the disorders would be highly desirable because not only would it lead to definitive therapy for the CDX, but it would provide valuable insights into the causes of skeletal deformities in general as well as normal bone growth. Unfortunately, the understanding of the abnormalities in the CDX has been hampered by a variety of problems primarily related to obtaining and investigating the affected tissue, the skeletal growth plate. Addressing these problems, the proposed investigator has developed an approach tailored to studying these disorders. It involves the use of highly specific histochemistry to localize matrix constituents in plastic embedded tissues combined with biochemical analysis of extremely small samples of cartilage. Preliminary studies have demonstrated its potential value as a means to probe the growth plate as a dynamic structure. It is now proposed to expand this approach to systematically and comprehensively examine endochondral ossification in growth plate tissue from normal control and CDX patients. The tissue will be studied by light and electron microscopic immune and lectin histochemistry, autoradiography, and in situ hybridization. Monoclonal antibodies to matrix components: types I-VI, IX (G), X (M), and 1Alpha, 2Alpha, 3Alpha collagens; chondroitin-4- and -6- sulfate, keratan sulfate and hyaluronic acid binding region substructures of cartilage proteoglycan; link protein; fibronectin; and cDNA probes to specific skeletal procollagen mRNAs will be employed. To biochemically confirm the microscopic observations, microsamples of the cartilages corresponding to different stages of chondrocyte proliferation and differentiation will be studied in organ culture by HPLC and SDS-PAGE methods to determine the presence of and relative proportions of isotopically labeled major and minor collagens and glycosaminoglycans in newly synthesized matrix. These studies should permit an accurate representation of the events of normal endochondral ossification to be constructed and defects therein to be identified.

Project Start
1985-08-01
Project End
1989-07-31
Budget Start
1985-08-01
Budget End
1986-07-31
Support Year
1
Fiscal Year
1985
Total Cost
Indirect Cost
Name
University of Texas Health Science Center Houston
Department
Type
Schools of Medicine
DUNS #
City
Houston
State
TX
Country
United States
Zip Code
77225
Maddox, B K; Garofalo, S; Horton, W A et al. (1998) Craniofacial and otic capsule abnormalities in a transgenic mouse strain with a Col2a1 mutation. J Craniofac Genet Dev Biol 18:195-201
Maddox, B K; Garofalo, S; Smith, C et al. (1997) Skeletal development in transgenic mice expressing a mutation at Gly574Ser of type II collagen. Dev Dyn 208:170-7
Horton, W A (1997) Fibroblast growth factor receptor 3 and the human chondrodysplasias. Curr Opin Pediatr 9:437-42
Maddox, B K; Garofalo, S; Keene, D R et al. (1997) Type II collagen pro-alpha-chains containing a Gly574Ser mutation are not incorporated into the cartilage matrix of transgenic mice. Matrix Biol 16:93-103
Horton, W A (1996) Evolution of the bone dysplasia family. Am J Med Genet 63:4-6
Horton, W A (1996) Progress in human chondrodysplasias: molecular genetics. Ann N Y Acad Sci 785:150-9
Horton, W A (1996) Molecular genetic basis of the human chondrodysplasias. Endocrinol Metab Clin North Am 25:683-97
Horton, W A (1995) Molecular genetics of the human chondrodysplasias-1995. Eur J Hum Genet 3:357-73
Bellus, G A; Hefferon, T W; Ortiz de Luna, R I et al. (1995) Achondroplasia is defined by recurrent G380R mutations of FGFR3. Am J Hum Genet 56:368-73
Brewton, R G; Wood, B M; Ren, Z X et al. (1995) Molecular cloning of the alpha 3 chain of human type IX collagen: linkage of the gene COL9A3 to chromosome 20q13.3. Genomics 30:329-36

Showing the most recent 10 out of 32 publications